These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 471140)

  • 21. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of insulin on the blood sugar level in the grass snake (Natrix natrix L.).
    Sidorkiewicz E; Skoczylas R
    Comp Biochem Physiol A Comp Physiol; 1974 Jul; 48(3):457-64. PubMed ID: 4151825
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
    Adair CM
    AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of insulin on lipoprotein lipase activity in the rat heart and adipose tissue.
    Borensztajn J; Samols DR; Rubenstein AH
    Am J Physiol; 1972 Dec; 223(6):1271-5. PubMed ID: 4641617
    [No Abstract]   [Full Text] [Related]  

  • 26. The minimal importance of the hollow viscera to peritoneal transport during peritoneal dialysis in the rat.
    Rubin J; Jones Q; Planch A; Bower JD
    ASAIO Trans; 1988; 34(4):912-5. PubMed ID: 3064790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution of a starch polymer for glucose in peritoneal dialysis.
    Rubin J; Jones Q; Planch A; Bower J; Klein E
    Nephron; 1985; 39(1):40-6. PubMed ID: 3969189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    De Santo NG; Capodicasa G; Senatore R; Cicchetti T; Cirillo D; Damiano M; Torella R; Giugliano D; Improta L; Giordano C
    Int J Artif Organs; 1979 May; 2(3):119-24. PubMed ID: 468403
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 30. [Measuring ionized calcium (Ca2+) transport during intermittent peritoneal dialysis (IPD)].
    Grzegorzewska A; Chalama B; Mariak I; Kupsz J
    Przegl Lek; 1997; 54(5):302-7. PubMed ID: 9380803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetylglucosamine- an osmotic slute for peritoneal dialysis without inducing hyperinsulinemia.
    Breborowicz A; Połubińska A; Simon M; Tam P; Wu G
    Blood Purif; 2004; 22(2):183-7. PubMed ID: 15044816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patients.
    Selgas R; Lopez-Rivas A; Alvaro F; Tarduchy GR; Rueda P; Muñoz J; Vara F
    Adv Perit Dial; 1989; 5():161-4. PubMed ID: 2577403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of centrally administered insulin on blood glucose levels in dogs.
    Agarwala GC; Mittal RK; Bapat SK; Bhardwaj UR
    Indian J Physiol Pharmacol; 1977; 21(1):11-8. PubMed ID: 873587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents.
    Lindholm B; Werynski A; Bergström J
    ASAIO Trans; 1987; 33(1):19-27. PubMed ID: 3828158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.
    Canepa A; Carrea A; Menoni S; Verrina E; Trivelli A; Gusmano R; Perfumo F
    Kidney Int; 2001 May; 59(5):1967-73. PubMed ID: 11318970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?
    Mehrotra R; de Boer IH; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):663-8. PubMed ID: 24076559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
    Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
    AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on transhepatic insulin absorption.
    Zingg W; Rappaport AM; Leibel BS
    Can J Physiol Pharmacol; 1986 Mar; 64(3):231-4. PubMed ID: 3518890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of glycemia in four routes of insulin administration in diabetic dogs.
    Rohde TD; Wigness BD; Rupp WM; Mauer SM; Dorman FD; Chapman RC; Blackshear PJ; Buchwald H
    Trans Am Soc Artif Intern Organs; 1983; 29():720-3. PubMed ID: 6369736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.